Form 4: Charles River Labs Executive Birgit Girshick Reports Stock and Options Transactions
SEC Form 4
Birgit Girshick, Corporate Executive VP & COO of Charles River Laboratories, reports acquisition of stock and options.
Summary
- On May 31, 2024, Birgit Girshick, Corporate Executive VP & COO of Charles River Laboratories, reported transactions involving the company's stock and options.
- Girshick acquired 3,838 shares of common stock at $0.
- Following the transaction, Girshick directly owns 50,512 shares of common stock.
- Girshick also acquired 8,722 stock options with an exercise price of $208.44, exercisable starting May 31, 2025, and expiring on May 31, 2034.
- These options also vest in installments until May 31, 2028.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing insider transactions. The acquisition of shares and options could be interpreted as a slightly positive sign of confidence, but it's not a strong indicator.
Positives
- The acquisition of shares and options by a company executive can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company executives.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives, ensuring transparency in insider trading activities.
- Similar filings are made by executives at comparable companies like Laboratory Corporation of America Holdings (LH) and Quest Diagnostics (DGX).
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of earliest transaction: Acquisition of common stock and stock options. |
| 05/31/2025 | First vesting date for restricted stock units (959 shares). |
| 05/31/2025 | First vesting date for stock options (2,180 options). |
| 05/31/2026 | Second vesting date for restricted stock units (960 shares). |
| 05/31/2026 | Second vesting date for stock options (2,181 options). |
| 05/31/2027 | Third vesting date for restricted stock units (959 shares). |
| 05/31/2027 | Third vesting date for stock options (2,180 options). |
| 05/31/2028 | Fourth vesting date for restricted stock units (960 shares). |
| 05/31/2028 | Fourth vesting date for stock options (2,181 options). |
| 05/31/2034 | Expiration date for stock options. |
| 06/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.